MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$69,935K
EPS
-$111.91
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
62,065
General and administrative
10,282
Total operating expenses
72,347
Loss from operations
-72,347
Interest income
1,562
Other income
790
Interest expense
0
Total other income, net
2,352
Loss before income taxes
-69,995
Federal tax at statutory rate
14,699
Permanent differences
-219
Research and development credits
-2,485
Change in valuation allowance
-16,965
Income tax benefit
0
Net loss
-69,995
Net unrealized gains on marketable securities
60
Total other comprehensive income
60
Total comprehensive loss
-69,935
Basic EPS
-111.91
Diluted EPS
-111.91
Basic Average Shares
744,991
Diluted Average Shares
744,991
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net unrealizedgains on marketable...$60K Total comprehensiveloss-$69,935K Total othercomprehensive income$60K Net loss-$69,995K Interest income$1,562K Other income$790K Loss before incometaxes-$69,995K Total other income,net$2,352K Loss from operations-$72,347K Total operatingexpenses$72,347K Research and development$62,065K General andadministrative$10,282K

Veradermics, Inc (MANE)

Veradermics, Inc (MANE)